Human cytomegalovirus (CMV) is a betaherpesvirus in the same family as human
herpesvirus-6 and-7. CMV is a large virus including approximately 200 proteins. CMV has …

Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …

Cytomegalovirus (CMV) remains one of the most common infections after solid organ
transplantation, resulting in significant morbidity, graft loss, and occasional mortality …

Cytomegalovirus (CMV) infections are among the most common infections that occur
following solid organ transplantation. CMV disease ranges from asymptomatic viremia, to …

Background. Cytomegalovirus (CMV) viremia that is resistant or refractory to the standard
antiviral therapy still constitutes a major threat to high-risk transplant recipients. In addition …

Cytomegalovirus (CMV) is a significant human pathogen, especially for
immunocompromised patients, often treated with one or more antiviral drugs. Although the …

Cytomegalovirus infection remains a major complication of solid organ transplantation. In
2005 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society …

Cytomegalovirus (CMV) infection is an important complication of solid-organ transplantation.
The availability of potent antiviral therapies has decreased the incidence of CMV disease …

Infection with human cytomegalovirus (HCMV) is a threat for pregnant women and
immunocompromised hosts. Although limited drugs are available, development of new …